News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NextBio Platform for Interpreting Genomic Data in Translational Research and Clinical Applications Passes HIPAA Audit


8/8/2012 10:33:34 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio announced today that their newly launched NextBio Clinical platform has successfully passed an independent 3rd party audit of NextBio’s security controls, meeting HIPAA (the federally mandated Health Insurance Portability and Accountability Act) requirements. NextBio demonstrated the implementation of physical, technical, and administrative controls to assure the confidentiality, integrity, and availability of electronic protected health information (ePHI) in its cloud-based NextBio Clinical platform. This successful HIPAA audit enables NextBio Clinical to host protected patient information as it integrates electronic medical records (EMRs) to further the use of genomics for translational medicine and research, as well as in the clinic. NextBio offers the world’s largest repository of curated and correlated molecular and clinical data.

Read at BioSpace.com

comments powered by Disqus
NextBio
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES